Perfluoroalkyl substances exposure and kidney function decline in a community-based prospective cohort
Open Access
- 10 September 2025
- journal article
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 303, 119015
Abstract
No abstract availableKeywords
Funding Information
- Chang Gung Memorial Hospital
- Chang Gung Medical Foundation (CLRPG2L0054)
- Chang Gung Medical Foundation (CRRPG2H0134)
This publication has 44 references indexed in Scilit:
- A review of cardiovascular effects and underlying mechanisms of legacy and emerging per- and polyfluoroalkyl substances (PFAS)Archives of Toxicology, 2023
- The use of in vitro methods in assessing human health risks associated with short‐chain perfluoroalkyl and polyfluoroalkyl substances (PFAS)Journal of Applied Toxicology, 2021
- Development of Risk Prediction Equations for Incident Chronic Kidney DiseaseJAMA, 2019
- Association Between Perfluoroalkyl Substance Exposure and Renal Function in Children With CKD Enrolled in H3Africa Kidney Disease Research NetworkKidney International Reports, 2019
- Perfluorooctane sulphonate induces oxidative hepatic damage via mitochondria-dependent and NF-κB/TNF-α-mediated pathwayChemosphere, 2018
- Endocrine-Disrupting ChemicalsJAMA Internal Medicine, 2016
- Changes in serum levels of perfluoroalkyl substances during a 10-year follow-up period in a large population-based cohortEnvironment International, 2016
- Decline in Estimated Glomerular Filtration Rate and Subsequent Risk of End-Stage Renal Disease and MortalityJAMA, 2014
- Effect of temperature and duration of storage on the stability of polyfluoroalkyl chemicals in human serumChemosphere, 2013
- Perfluoroalkyl and polyfluoroalkyl substances in the environment: Terminology, classification, and originsIntegrated Environmental Assessment and Management, 2011